Evelo biosciences, inc. (EVLO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating expenses:
Research and development

64,867

63,128

58,097

53,714

48,422

39,885

34,618

28,736

23,254

19,957

0

0

0

General and administrative

23,947

23,229

21,583

20,927

20,060

18,218

15,559

13,022

9,494

7,574

0

0

0

Total operating expenses

88,814

86,357

79,680

74,641

68,482

58,103

50,177

41,758

32,748

27,531

0

0

0

Loss from operations

-88,814

-86,357

-79,680

-74,641

-68,482

-58,103

-50,177

-41,758

-32,748

-27,531

0

0

0

Other (expense) income:
Interest (expense) income, net

363

1,049

1,582

2,101

2,022

1,563

1,014

345

-97

-215

0

0

0

Other income

0

-

-

-

0

-

-

-

-

-

-

-

-

Other expenses

-

-

218

0

-

-

483

549

332

-

0

0

0

Other income, net

855

1,075

1,364

2,101

1,737

1,157

531

-204

-429

-516

0

0

0

Loss before income taxes

0

-

-

-

0

-

-

-

-

-

-

-

-

Income tax expense

0

-

-

-

0

-

-

-

-

-

-

-

-

Net loss

-88,214

-85,472

-78,316

-72,540

-66,745

-56,946

-49,646

-41,962

-33,177

-28,047

0

0

0

Convertible preferred stock dividends

-

-

0

0

-

3,937

5,667

7,375

7,277

6,085

0

0

0

Net loss attributable to common stockholders

-

-

-78,316

-72,540

-

-60,883

-55,313

-49,337

-40,454

-34,132

0

0

0

Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)

-0.71

-0.71

-0.67

-0.65

-0.64

-0.49

-0.50

-0.85

-3.29

-2.57

-2.61

-2.09

-1.81

Weighted-average number of common shares outstanding, basic and diluted (in shares)

32,250

32,100

32,060

32,041

31,925

32,193

31,741

19,626

3,922

3,840

3,779

3,730

3,651

Comprehensive loss:
Reconciliation of net loss to net loss attributable to common stockholders:
Net loss

-88,214

-85,472

-78,316

-72,540

-66,745

-56,946

-49,646

-41,962

0

0

0

-

-

Net Income (Loss) Attributable to Parent

0

-

-

-

0

-

-

-

-

-

-

-

-

Other comprehensive loss:
Unrealized gain (loss) on investments, net of tax of $0

2

18

38

1

-2

-18

-38

0

0

-

0

-

-

Comprehensive loss

-88,154

-85,454

-78,290

-72,556

-66,764

-56,964

-49,719

0

0

-

0

-

-